Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Emerging Markets · T. Rowe Price

MXEOX Alternatives & Equivalents

Ticker MXEOX · Since 2018-01-04 · · Holdings as of Jun 30, 2026

Expense ratio
1.26%$126/yr per $10k
5-yr return
+3.5%annualized
1-yr return
+32.8%as of Dec 2025
Net assets
$2.0Ball share classes
Holdings
306

Bottom line

What is similar to MXEOX?

We compared MXEOX's top holdings against every emerging markets fund. The closest match is NOEMX (Emerging Markets Equity Index Fund), with about 73% portfolio overlap. The cheapest similar fund is NOEMX at 0.15% vs 1.26% for MXEOX. Equivalents exist at Fidelity.

MXEOX equivalent at each fund company

Useful if your 401(k) or brokerage only offers one family's funds — for example, the Fidelity or Schwab equivalent of MXEOX.

Best overlap match per family (minimum 50% overlap)
FamilyEquivalentExpense ratio5-yr returnOverlap
Fidelity equivalent of MXEOXIEMIX ABS Insights Emerging Markets Fund1.13%—64%

Funds most similar to MXEOX

Ranked by top-holdings overlap
FundFamilyExpense ratio5-yr returnOverlap
NOEMX Emerging Markets Equity Index FundNorthern Trust (FlexShares)0.15%+3.7%73% Compare
TEMUX Emerging Markets Equity FundMorgan Stanley0.75%−0.6%72% Compare
TEQSX Nuveen Emerging Markets Equity Index…Nuveen / TIAA0.4%+3.6%70% Compare
IEMIX ABS Insights Emerging Markets FundFidelity1.13%—64% Compare
DAEMX Dunham Emerging Markets Stock FundDunham1.46%−0.5%60% Compare
POLEX Polar Capital Emerging Market Stars FundDatum One1%+1.4%57% Compare
TSEGX Touchstone Sands Capital Emerging…Touchstone1.04%−4.2%56% Compare
NUEM Nuveen ESG Emerging Markets Equity ETFNuveen / TIAA0.36%+3.8%56% Compare
DIEMX Driehaus Emerging Markets Growth FundDriehaus Mutual0.91%+3.6%54% Compare
TEMSX Nuveen Emerging Markets Equity FundNuveen / TIAA1.14%+0.4%53% Compare

Overlap = share of the two funds' top-25 holdings (by weight) that they have in common, from SEC Form N-PORT. Funds that hold other funds are matched by benchmark when holdings aren't comparable.